Wright Medical Group Inc (WMGIZ) 4.20 $WMGIZ
Wright Medical Group, Inc. Prices $550 Million Cash Convertible Senior Notes Offering
GlobeNewswire - Tue Feb 10, 6:25AM CST
Wright Medical Group, Inc. (Nasdaq:WMGI) (the "Company"
today announced the pricing of its offering of $550 million aggregate principal amount of cash convertible senior notes due 2020 ("the notes" . The notes were sold to initial purchasers who are reselling the notes to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The Company also granted the initial purchasers a 30-day option to purchase up to an additional $82.5 million aggregate principal amount of notes solely to cover over-allotments. The offering is expected to close on February 13, 2015, subject to customary closing conditions.
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Wright Medical Group, Inc. Announces Proposed Private Placement of Cash Convertible Senior Notes
GlobeNewswire - Mon Feb 09, 6:18AM CST
Wright Medical Group, Inc. (Nasdaq:WMGI) (the "Company" today announced its intention to commence an offering, subject to market and other conditions, of $400 million aggregate principal amount of cash convertible senior notes due 2020 (the "notes" , to be offered and sold to initial purchasers who would resell the notes to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The Company intends to grant the initial purchasers a 30-day option to purchase up to an additional $60 million aggregate principal amount of notes solely to cover over-allotments.
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Wright Medical Group, Inc. to Host Fourth Quarter 2014 Earnings Conference Call
GlobeNewswire - Wed Feb 04, 3:07PM CST
Wright Medical Group, Inc. (Nasdaq:WMGI) today announced that it will host a conference call on Wednesday, February 25, 2015, at 3:30 p.m. Central Time to discuss the Company's operating results for its fourth quarter ended December 31, 2014. Operating results will be released at 3:00 p.m. Central Time that day.
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Wright Medical Group, Inc. Announces Receipt of Second Request From Federal Trade Commission Regarding Proposed Merger With Tornier N.V.
GlobeNewswire - Mon Feb 02, 3:00PM CST
Wright Medical Group, Inc. (Nasdaq:WMGI) today announced that on January 28, 2015 it received from the Federal Trade Commission ("FTC" a Request for Additional Information and Documentary Material (commonly known as a "Second Request" in connection with its proposed merger with Tornier N.V. Wright also announced that the previously disclosed pending pre-approval inspection of an Augment Bone Graft vendor had concluded and resulted in the issuance of a Form 483 containing certain observations to which the vendor has already responded.
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Technical Commentary on Health Care Equipment Stocks - Hologic, St. Jude Medical, Covidien, Wright Medical, and Zeltiq Aesthetics
PR Newswire - Wed Jan 14, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: Hologic Inc. (NASDAQ: HOLX), St Jude Medical Inc. (NYSE: STJ), Covidien PLC (NYSE: COV), Wright Medical Group Inc. (NASDAQ: WMGI), and Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Tuesday, January 13, 2015, the NASDAQ Composite ended at 4,661.50, down 0.07%, the Dow Jones Industrial Average edged 0.15% lower, to finish the day at 17,613.68, and the S&P 500 closed at 2,023.03, down 0.26%. The losses were broad based as eight out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 808.73, down 0.49%, while the index has advanced 13.71% in the last three months. Register for your complimentary reports on these five stocks at:
ZLTQ: 34.48 (+0.28), WMGI: 25.68 (+0.17), COV: 106.71 (-1.36), STJ: 67.48 (+0.65), WMGIZ: 4.20 (-0.05), HOLX: 30.46 (+0.21)
SHAREHOLDER ALERT: Law Firm of Levi & Korsinsky, LLP Notifies Investors of Wright Medical Group, Inc. of Class Action Against Board of Directors of the Company Regarding the Fairness of the Sale of the Company to Tornier NV -- WMGI
GlobeNewswire - Mon Jan 12, 4:28PM CST
Levi & Korsinsky is investigating the Board of Directors of Wright Medical Group, Inc. ("Wright Medical" or "the Company" (NasdaqGS:WMGI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Tornier NV. A complaint was filed in Delaware state court.
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05), TRNX: 25.32 (+0.12)
Wright Medical Group, Inc. Announces Preliminary Fourth Quarter and Full Year 2014 Revenue
GlobeNewswire - Mon Jan 12, 5:35AM CST
Fourth Quarter Global Foot and Ankle Net Sales Expected to Increase Approximately 33% As Reported and 34% Constant Currency
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Wright Medical Group, Inc. to Participate in 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Thu Dec 18, 3:00PM CST
Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it will be participating in the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2015, at the Westin St. Francis Hotel in San Francisco, California. Robert Palmisano, president and chief executive officer, will present at 2:30 p.m. Pacific Time.
WMGI: 25.68 (+0.17), JPM: 59.67 (+0.10), WMGIZ: 4.20 (-0.05)
APAC Joint Replacement And Joint Reconstruction Market Through 2020 - Analysis of the $6.4 Billion Market
M2 - Tue Dec 16, 8:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/whpkzp/apac_joint) has announced the addition of the "APAC Joint Replacement And Joint Reconstruction Market Through 2020" report to their offering. The Joint Replacement and Joint Reconstruction Market, comprising hip replacement, knee replacement, shoulder replacement and small joint replacement, in the Asia Pacific (APAC) is projected to reach $6.4 billion by 2020 with hip arthroplasty and knee arthroplasty are the most common types of joint replacements in APAC. Currently, the growth in the region is driven by chronic medical conditions such as osteoarthritis, rheumatoid arthritis and osteoporosis; technical advancement in implant designs; new joint biomaterials; and robotic and minimally invasive surgeries (MIS). Also, the market is pushed by favorable macroeconomic factors, especially in India and China. The future growth would be driven by the above-mentioned chronic conditions, younger patients undergoing joint replacement and requiring further revision surgeries during their lifetime. The market's growth would also be fuelled by improved healthcare infrastructure, better diagnosis facilities, and favorable macro economic factors such as increasing disposable income and rising healthcare expenditure. Also, a decline in sales and pricing pressure in the US and other developed markets has forced companies to increase their focus on the APAC region. China and India offer a huge potential for market growth due to their developing economies and the size of the population. The key attributes that will govern the market in this region will be innovation, technology, reduced cost and existing products that are refined. Key Topics Covered: - Market at a Glance - Summary - China Market for Joint Replacement and Joint Reconstruction (2007-2020) - Japan Market for Joint Replacement and Joint Reconstruction (2007-2020) - Australia Market for Joint Replacement and Joint Reconstruction (2007-2020) - India Market for Joint Replacement and Joint Reconstruction (2007-2020) - Korea Market for Joint Replacement and Joint Reconstruction (2007-2020) - Recent Industry Activity - Appendix - Research Methodology - Market segmentation - Joint Replacement and Joint Reconstruction - Definitions - Disclaimer Companies Mentioned - DePuy Medical Pty. Ltd - Implants International Ltd. - Japan Medical Dynamic Marketing Inc. (TSE:7600) - KYOCERA Medical Corporation - Mathys Medical - OMNI Life Science - Smith & Nephew plc (NYSE: SNN; LSE: SN) - Stryker Corporation(SYK) and Zimmer Holdings Inc (ZMH) - Waldemar LINK - Wright Medical Group Inc. (WMGI) For more information visit http://www.researchandmarkets.com/research/whpkzp/apac_joint
SNN: 35.82 (-0.28), WMGIZ: 4.20 (-0.05), SYK: 94.51 (+1.14)
Robbins Arroyo LLP Is Investigating the Officers and Directors of Wright Medical Group, Inc. (WMGI) on Behalf of Shareholders
PR Newswire - Fri Nov 21, 5:59PM CST
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Wright Medical Group, Inc. (NASDAQGS: WMGI) breached their fiduciary duties to shareholders. Wright Medical is a specialty orthopaedic company that offers biologic and extremity solutions worldwide.
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Wright Medical Group, Inc. to Participate in Piper Jaffray Healthcare Conference
Business Wire - Tue Nov 18, 5:00AM CST
Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it will be participating in the Piper Jaffray Healthcare Conference on Tuesday, December 2, 2014, at the New York Palace Hotel in New York, NY. Robert Palmisano, president and chief executive officer, will present at 11:00 a.m. Eastern Time.
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Wright Medical Group, Inc. in Connection with the Sale of the Company
Business Wire - Tue Nov 11, 9:05PM CST
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Wright Medical Group, Inc. ("Wright Medical" or the "Company" (Nasdaq: WMGI) relating to the proposed acquisition by Tornier N.V. ("Tornier" .
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Global Bio-implants Market (Types, and geography) - Forecast to 2020
M2 - Fri Nov 07, 6:14AM CST
Research and Markets (http://www.researchandmarkets.com/research/57vlzn/global) has announced the addition of the "Global Bio-implants Market (Types, and geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020 " report to their offering. Bio-implants have emerged as a promising solution for the variety of conditions such as cardiovascular, dental, orthopedic, ophthalmology, neurological disorders and others. Global bio implants market is forecast to reach $115.8 billion by 2020. High prevalence of disease conditions such as cardiovascular, orthopedic and spinal disorders that can be treated via bio implants are the key drivers of the bio implants market. According to American College Of Surgeons, 29% of the trauma injuries were caused by road accidents; the instances of road accidents and death due to the same are rising to about 2.2% globally. Such patients undergoing traumatic injuries can be effectively treated with bio implants. Such afore-mentioned factor and multifarious analogous factors across cardiovascular, spinal and ophthalmic disorders drive the growth of the bio implants market. The global bio-implants market is segmented based on product types and geography. Within the product types, the bio implants market is segmented into cardiovascular, dental and prosthetic implants, orthopedic/joint reconstruction and replacement bio implants, spinal bio implants, ophthalmology bio implants and others. Geographically, the market is segmented into four regions, namely North America, Europe, Asia-Pacific and LAMEA. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 GLOBAL BIOIMPLANTS MARKET OVERVIEW CHAPTER 4 GLOBAL BIO IMPLANTS MARKET BY TYPES CHAPTER 5 GLOBAL BIO IMPLANTS MARKET BY GEOGRAPHY CHAPTER 6 EUROPEAN BIO IMPLANTS MARKET ANALYSIS CHAPTER 7 COMPANY PROFILE Companies Mentioned: - B.Braun - BIOMET (Zimmer) - Biotroni - DENTSPLY International - DePuy Synthes - Ethicon Inc. - Invibio Biomaterial Solutions - kasios - KLS Martin - Mediplus - Medtronic, Inc. - SBM (Science for Biomaterials) - Smith & Nephews - Stryker Corporation - Wright Medical Group For more information visit http://www.researchandmarkets.com/research/57vlzn/global
MDT: 75.26 (+0.33), WMGIZ: 4.20 (-0.05), XRAY: 52.74 (+0.32), SYK: 94.51 (+1.14)
The Wright Medical Group, Inc. Acquisition By Tornier N.V. May Not Be In The Best Interests of WMGI Shareholders
PR Newswire - Thu Nov 06, 2:45PM CST
The fairness of the proposed acquisition of Wright Medical Group, Inc. ("WMGI" or the "Company" by Tornier N.V. ("Tornier" is the subject of an examination by WeissLaw LLP, a national class action, shareholder rights law firm. The examination is focusing on possible breaches of fiduciary duty and other violations of law by the Board of Directors of WMGI for agreeing to sell the Company to Tornier. On October 27, 2014, the Company announced it had reached a definitive agreement for Tornier to acquire WMGI in a transaction valued at approximately $3.3 billion. Under the terms of the agreement, WMGI shareholders will receive 1.0309 shares of Tornier for each WMGI share they own. Based on Tornier's closing stock price on October 24, 2014, the consideration is valued at $24.32.
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
MCRA Assists Wright Medical Group, Inc. with Obtaining FDA PMA Approvable Decision for Augment® Bone Graft
PR Newswire - Thu Nov 06, 7:37AM CST
Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) announced today its role in the successful approvable decision by the U.S. Food and Drug Administration (FDA) for Wright Medical Group, Inc.'s (NASDAQ: WMGI) Augment® Bone Graft Premarket Approval Application (PMA), for use as an alternative to autograft for ankle and/or hindfoot fusion procedures. Wright announced the approvable decision on October 27, 2014.
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Wright Medical Group, Inc. Reports 2014 Third Quarter Financial Results and Updated Guidance
Business Wire - Wed Nov 05, 3:00PM CST
--Third Quarter Sales Increase 24% As Reported and 24% Constant Currency
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Merger Arbitrage Mondays - November 3, 2014
Asif Suria - Seeking Alpha - Mon Nov 03, 12:35PM CST
Merger Activity increased last week with five new mergers announced. None of the pending deals closed last week. You can find all the active deals listed below in our Merger Arbitrage Tool that automatically updates itself during market hours. ...
ESBF: 17.77 (+0.05), AVIV: 36.45 (-0.08), ACMP: 48.15 (-3.60), CPWR: 10.35 (+0.01), WSBC: 33.14 (-0.09), CQB: 14.49 (unch), OHI: 40.61 (-0.06), TRNX: 25.32 (+0.12), WMGIZ: 4.20 (-0.05), COVS: 2.47 (+0.11), WPZ: 47.43 (+0.98)
Wright Medical Group, Inc. to Host Third Quarter 2014 Earnings Conference Call
Business Wire - Mon Nov 03, 5:00AM CST
Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it will host a conference call on Wednesday, November 5, 2014, at 3:30 p.m. Central Time to discuss the Company's operating results for its third quarter ended September 30, 2014. Operating results will be released at 3:00 p.m. Central Time that day.
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Wright Medical Group, Inc. to Participate in Credit Suisse 2014 Healthcare Conference
Business Wire - Mon Nov 03, 5:00AM CST
Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it will be participating in the Credit Suisse 2014 Healthcare Conference on Wednesday, November 12, 2014, at the Arizona Biltmore Hotel in Phoenix, Arizona. Lance Berry, senior vice president and chief financial officer, will present at 9:30 a.m. Mountain Time / 11:30 a.m. Eastern Time.
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Wright Medical Group, Inc. Prices $550 Million Cash Convertible Senior Notes Offering
GlobeNewswire - Tue Feb 10, 6:25AM CST
Wright Medical Group, Inc. (Nasdaq:WMGI) (the "Company"
today announced the pricing of its offering of $550 million aggregate principal amount of cash convertible senior notes due 2020 ("the notes" . The notes were sold to initial purchasers who are reselling the notes to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The Company also granted the initial purchasers a 30-day option to purchase up to an additional $82.5 million aggregate principal amount of notes solely to cover over-allotments. The offering is expected to close on February 13, 2015, subject to customary closing conditions. WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Wright Medical Group, Inc. Announces Proposed Private Placement of Cash Convertible Senior Notes
GlobeNewswire - Mon Feb 09, 6:18AM CST
Wright Medical Group, Inc. (Nasdaq:WMGI) (the "Company"
today announced its intention to commence an offering, subject to market and other conditions, of $400 million aggregate principal amount of cash convertible senior notes due 2020 (the "notes" , to be offered and sold to initial purchasers who would resell the notes to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The Company intends to grant the initial purchasers a 30-day option to purchase up to an additional $60 million aggregate principal amount of notes solely to cover over-allotments. WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Wright Medical Group, Inc. to Host Fourth Quarter 2014 Earnings Conference Call
GlobeNewswire - Wed Feb 04, 3:07PM CST
Wright Medical Group, Inc. (Nasdaq:WMGI) today announced that it will host a conference call on Wednesday, February 25, 2015, at 3:30 p.m. Central Time to discuss the Company's operating results for its fourth quarter ended December 31, 2014. Operating results will be released at 3:00 p.m. Central Time that day.
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Wright Medical Group, Inc. Announces Receipt of Second Request From Federal Trade Commission Regarding Proposed Merger With Tornier N.V.
GlobeNewswire - Mon Feb 02, 3:00PM CST
Wright Medical Group, Inc. (Nasdaq:WMGI) today announced that on January 28, 2015 it received from the Federal Trade Commission ("FTC"
a Request for Additional Information and Documentary Material (commonly known as a "Second Request" in connection with its proposed merger with Tornier N.V. Wright also announced that the previously disclosed pending pre-approval inspection of an Augment Bone Graft vendor had concluded and resulted in the issuance of a Form 483 containing certain observations to which the vendor has already responded. WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Technical Commentary on Health Care Equipment Stocks - Hologic, St. Jude Medical, Covidien, Wright Medical, and Zeltiq Aesthetics
PR Newswire - Wed Jan 14, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: Hologic Inc. (NASDAQ: HOLX), St Jude Medical Inc. (NYSE: STJ), Covidien PLC (NYSE: COV), Wright Medical Group Inc. (NASDAQ: WMGI), and Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Tuesday, January 13, 2015, the NASDAQ Composite ended at 4,661.50, down 0.07%, the Dow Jones Industrial Average edged 0.15% lower, to finish the day at 17,613.68, and the S&P 500 closed at 2,023.03, down 0.26%. The losses were broad based as eight out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 808.73, down 0.49%, while the index has advanced 13.71% in the last three months. Register for your complimentary reports on these five stocks at:
ZLTQ: 34.48 (+0.28), WMGI: 25.68 (+0.17), COV: 106.71 (-1.36), STJ: 67.48 (+0.65), WMGIZ: 4.20 (-0.05), HOLX: 30.46 (+0.21)
SHAREHOLDER ALERT: Law Firm of Levi & Korsinsky, LLP Notifies Investors of Wright Medical Group, Inc. of Class Action Against Board of Directors of the Company Regarding the Fairness of the Sale of the Company to Tornier NV -- WMGI
GlobeNewswire - Mon Jan 12, 4:28PM CST
Levi & Korsinsky is investigating the Board of Directors of Wright Medical Group, Inc. ("Wright Medical" or "the Company"
(NasdaqGS:WMGI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Tornier NV. A complaint was filed in Delaware state court. WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05), TRNX: 25.32 (+0.12)
Wright Medical Group, Inc. Announces Preliminary Fourth Quarter and Full Year 2014 Revenue
GlobeNewswire - Mon Jan 12, 5:35AM CST
Fourth Quarter Global Foot and Ankle Net Sales Expected to Increase Approximately 33% As Reported and 34% Constant Currency
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Wright Medical Group, Inc. to Participate in 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Thu Dec 18, 3:00PM CST
Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it will be participating in the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2015, at the Westin St. Francis Hotel in San Francisco, California. Robert Palmisano, president and chief executive officer, will present at 2:30 p.m. Pacific Time.
WMGI: 25.68 (+0.17), JPM: 59.67 (+0.10), WMGIZ: 4.20 (-0.05)
APAC Joint Replacement And Joint Reconstruction Market Through 2020 - Analysis of the $6.4 Billion Market
M2 - Tue Dec 16, 8:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/whpkzp/apac_joint) has announced the addition of the "APAC Joint Replacement And Joint Reconstruction Market Through 2020" report to their offering. The Joint Replacement and Joint Reconstruction Market, comprising hip replacement, knee replacement, shoulder replacement and small joint replacement, in the Asia Pacific (APAC) is projected to reach $6.4 billion by 2020 with hip arthroplasty and knee arthroplasty are the most common types of joint replacements in APAC. Currently, the growth in the region is driven by chronic medical conditions such as osteoarthritis, rheumatoid arthritis and osteoporosis; technical advancement in implant designs; new joint biomaterials; and robotic and minimally invasive surgeries (MIS). Also, the market is pushed by favorable macroeconomic factors, especially in India and China. The future growth would be driven by the above-mentioned chronic conditions, younger patients undergoing joint replacement and requiring further revision surgeries during their lifetime. The market's growth would also be fuelled by improved healthcare infrastructure, better diagnosis facilities, and favorable macro economic factors such as increasing disposable income and rising healthcare expenditure. Also, a decline in sales and pricing pressure in the US and other developed markets has forced companies to increase their focus on the APAC region. China and India offer a huge potential for market growth due to their developing economies and the size of the population. The key attributes that will govern the market in this region will be innovation, technology, reduced cost and existing products that are refined. Key Topics Covered: - Market at a Glance - Summary - China Market for Joint Replacement and Joint Reconstruction (2007-2020) - Japan Market for Joint Replacement and Joint Reconstruction (2007-2020) - Australia Market for Joint Replacement and Joint Reconstruction (2007-2020) - India Market for Joint Replacement and Joint Reconstruction (2007-2020) - Korea Market for Joint Replacement and Joint Reconstruction (2007-2020) - Recent Industry Activity - Appendix - Research Methodology - Market segmentation - Joint Replacement and Joint Reconstruction - Definitions - Disclaimer Companies Mentioned - DePuy Medical Pty. Ltd - Implants International Ltd. - Japan Medical Dynamic Marketing Inc. (TSE:7600) - KYOCERA Medical Corporation - Mathys Medical - OMNI Life Science - Smith & Nephew plc (NYSE: SNN; LSE: SN) - Stryker Corporation(SYK) and Zimmer Holdings Inc (ZMH) - Waldemar LINK - Wright Medical Group Inc. (WMGI) For more information visit http://www.researchandmarkets.com/research/whpkzp/apac_joint
SNN: 35.82 (-0.28), WMGIZ: 4.20 (-0.05), SYK: 94.51 (+1.14)
Robbins Arroyo LLP Is Investigating the Officers and Directors of Wright Medical Group, Inc. (WMGI) on Behalf of Shareholders
PR Newswire - Fri Nov 21, 5:59PM CST
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Wright Medical Group, Inc. (NASDAQGS: WMGI) breached their fiduciary duties to shareholders. Wright Medical is a specialty orthopaedic company that offers biologic and extremity solutions worldwide.
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Wright Medical Group, Inc. to Participate in Piper Jaffray Healthcare Conference
Business Wire - Tue Nov 18, 5:00AM CST
Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it will be participating in the Piper Jaffray Healthcare Conference on Tuesday, December 2, 2014, at the New York Palace Hotel in New York, NY. Robert Palmisano, president and chief executive officer, will present at 11:00 a.m. Eastern Time.
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Wright Medical Group, Inc. in Connection with the Sale of the Company
Business Wire - Tue Nov 11, 9:05PM CST
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Wright Medical Group, Inc. ("Wright Medical" or the "Company"
(Nasdaq: WMGI) relating to the proposed acquisition by Tornier N.V. ("Tornier" . WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Global Bio-implants Market (Types, and geography) - Forecast to 2020
M2 - Fri Nov 07, 6:14AM CST
Research and Markets (http://www.researchandmarkets.com/research/57vlzn/global) has announced the addition of the "Global Bio-implants Market (Types, and geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020 " report to their offering. Bio-implants have emerged as a promising solution for the variety of conditions such as cardiovascular, dental, orthopedic, ophthalmology, neurological disorders and others. Global bio implants market is forecast to reach $115.8 billion by 2020. High prevalence of disease conditions such as cardiovascular, orthopedic and spinal disorders that can be treated via bio implants are the key drivers of the bio implants market. According to American College Of Surgeons, 29% of the trauma injuries were caused by road accidents; the instances of road accidents and death due to the same are rising to about 2.2% globally. Such patients undergoing traumatic injuries can be effectively treated with bio implants. Such afore-mentioned factor and multifarious analogous factors across cardiovascular, spinal and ophthalmic disorders drive the growth of the bio implants market. The global bio-implants market is segmented based on product types and geography. Within the product types, the bio implants market is segmented into cardiovascular, dental and prosthetic implants, orthopedic/joint reconstruction and replacement bio implants, spinal bio implants, ophthalmology bio implants and others. Geographically, the market is segmented into four regions, namely North America, Europe, Asia-Pacific and LAMEA. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 GLOBAL BIOIMPLANTS MARKET OVERVIEW CHAPTER 4 GLOBAL BIO IMPLANTS MARKET BY TYPES CHAPTER 5 GLOBAL BIO IMPLANTS MARKET BY GEOGRAPHY CHAPTER 6 EUROPEAN BIO IMPLANTS MARKET ANALYSIS CHAPTER 7 COMPANY PROFILE Companies Mentioned: - B.Braun - BIOMET (Zimmer) - Biotroni - DENTSPLY International - DePuy Synthes - Ethicon Inc. - Invibio Biomaterial Solutions - kasios - KLS Martin - Mediplus - Medtronic, Inc. - SBM (Science for Biomaterials) - Smith & Nephews - Stryker Corporation - Wright Medical Group For more information visit http://www.researchandmarkets.com/research/57vlzn/global
MDT: 75.26 (+0.33), WMGIZ: 4.20 (-0.05), XRAY: 52.74 (+0.32), SYK: 94.51 (+1.14)
The Wright Medical Group, Inc. Acquisition By Tornier N.V. May Not Be In The Best Interests of WMGI Shareholders
PR Newswire - Thu Nov 06, 2:45PM CST
The fairness of the proposed acquisition of Wright Medical Group, Inc. ("WMGI" or the "Company"
by Tornier N.V. ("Tornier" is the subject of an examination by WeissLaw LLP, a national class action, shareholder rights law firm. The examination is focusing on possible breaches of fiduciary duty and other violations of law by the Board of Directors of WMGI for agreeing to sell the Company to Tornier. On October 27, 2014, the Company announced it had reached a definitive agreement for Tornier to acquire WMGI in a transaction valued at approximately $3.3 billion. Under the terms of the agreement, WMGI shareholders will receive 1.0309 shares of Tornier for each WMGI share they own. Based on Tornier's closing stock price on October 24, 2014, the consideration is valued at $24.32. WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
MCRA Assists Wright Medical Group, Inc. with Obtaining FDA PMA Approvable Decision for Augment® Bone Graft
PR Newswire - Thu Nov 06, 7:37AM CST
Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) announced today its role in the successful approvable decision by the U.S. Food and Drug Administration (FDA) for Wright Medical Group, Inc.'s (NASDAQ: WMGI) Augment® Bone Graft Premarket Approval Application (PMA), for use as an alternative to autograft for ankle and/or hindfoot fusion procedures. Wright announced the approvable decision on October 27, 2014.
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Wright Medical Group, Inc. Reports 2014 Third Quarter Financial Results and Updated Guidance
Business Wire - Wed Nov 05, 3:00PM CST
--Third Quarter Sales Increase 24% As Reported and 24% Constant Currency
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Merger Arbitrage Mondays - November 3, 2014
Asif Suria - Seeking Alpha - Mon Nov 03, 12:35PM CST
Merger Activity increased last week with five new mergers announced. None of the pending deals closed last week. You can find all the active deals listed below in our Merger Arbitrage Tool that automatically updates itself during market hours. ...
ESBF: 17.77 (+0.05), AVIV: 36.45 (-0.08), ACMP: 48.15 (-3.60), CPWR: 10.35 (+0.01), WSBC: 33.14 (-0.09), CQB: 14.49 (unch), OHI: 40.61 (-0.06), TRNX: 25.32 (+0.12), WMGIZ: 4.20 (-0.05), COVS: 2.47 (+0.11), WPZ: 47.43 (+0.98)
Wright Medical Group, Inc. to Host Third Quarter 2014 Earnings Conference Call
Business Wire - Mon Nov 03, 5:00AM CST
Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it will host a conference call on Wednesday, November 5, 2014, at 3:30 p.m. Central Time to discuss the Company's operating results for its third quarter ended September 30, 2014. Operating results will be released at 3:00 p.m. Central Time that day.
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
Wright Medical Group, Inc. to Participate in Credit Suisse 2014 Healthcare Conference
Business Wire - Mon Nov 03, 5:00AM CST
Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it will be participating in the Credit Suisse 2014 Healthcare Conference on Wednesday, November 12, 2014, at the Arizona Biltmore Hotel in Phoenix, Arizona. Lance Berry, senior vice president and chief financial officer, will present at 9:30 a.m. Mountain Time / 11:30 a.m. Eastern Time.
WMGI: 25.68 (+0.17), WMGIZ: 4.20 (-0.05)
